Beta Bionics (BBNX) vs iRadimed (IRMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
iRadimed (IRMD) has outperformed Beta Bionics (BBNX) over the past year, gaining 11.7% versus a loss of 21.2%. iRadimed is the larger company by market cap ($1.11 billion vs $937.3 million), about 1.2 times the size. iRadimed pays a dividend yielding 0.89%, while Beta Bionics does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BBNX | IRMD |
|---|---|---|
| Share price | $17.38 | $86.72 |
| Market cap | $937.32M | $1.11B |
| 1-day change | -0.32% | +0.98% |
| YTD return | -42.80% | -11.72% |
| 1-year return | -21.24% | +11.72% |
| 5-year return | — | +134.20% |
| P/E ratio (TTM) | — | 48.45 |
| Forward P/E | — | 35.35 |
| EPS (TTM) | $-1.64 | $1.79 |
| Dividend yield | 0.00% | 0.89% |
| Annual dividend | $0.00 | $0.77 |
| 52-week high | $32.71 | $107.90 |
| 52-week low | $8.80 | $71.34 |
| Distance from 52-week high | -46.88% | -19.63% |
| Analyst consensus | buy | none |
| Avg. price target upside | +36.98% | +36.07% |
| Average volume | 1.31M | 125.83K |
| Shares outstanding | 53.95M | 12.79M |
| Employees | 420 | 166 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IRMD has outperformed BBNX by 33.0 percentage points over the past year.
About Beta Bionics
BBNX stock →Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older.
Health Care · Medical/Dental Instruments · 420 employees
About iRadimed
IRMD stock →IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.
Health Care · Medical/Dental Instruments · 166 employees
BBNX vs IRMD FAQ
Which is bigger, Beta Bionics or iRadimed?
iRadimed (IRMD) is larger, with a market capitalization of $1.11B compared with $937.32M for Beta Bionics (BBNX).
Which stock has performed better over the past year, BBNX or IRMD?
IRMD returned +11.72% over the past 12 months, compared with -21.24% for BBNX (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Beta Bionics or iRadimed?
iRadimed pays a dividend yielding 0.89%, while Beta Bionics does not currently pay a regular dividend.
Are Beta Bionics and iRadimed in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.